Remote Ischemic Preconditioning and Contrast Induced - Acute Kidney Injury in Patients Undergoing Elective PCI

NCT ID: NCT03761368

Last Updated: 2020-11-19

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

101 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-03-01

Study Completion Date

2018-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prospective, randomized, sham-controlled clinical study was conducted to assess whether RIPC reduces the incidence of CI-AKI measured standard way of using SCr concentration but also with the use of serum NGAL as a new potential biomarker of kidney injury. Furthermore, the aim of investigation was to analyse the safety and clinical outcomes of RIPC after elective coronary angiography (CA) followed by percutaneous coronary intervention (PCI).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Nowadays CI-AKI is defined according to serum creatinine concentration (SCr) as any of the following: (1) an absolute rise of ≥ 0.5 mg/dL (44 µmol/L) and/or (2) a relative increase of 25% in serum creatinine compared to baseline within 48 to 72 hours after contrast administration. In the last decades, several novel biomarkers of AKI have been studied including neutrophil gelatinase-associated lipocalin (NGAL). Furthermore, remote ischemic preconditioning (RIPC) turned out to be one of the most promising and intriguing non-pharmacological strategy. This simple procedure consisting of brief, non-lethal episodes of ischemia and reperfusion applied in one tissue or organ protects remote tissues or organs from subsequent injury.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Remote Ischemic Preconditioning Contrast Induced - Acute Kidney Injury

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

remote ischemic preconditioning contrast induced-acute kidney injury neutrophil gelatinase-associated lipocalin percutaneous coronary intervention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

After admission to the Department, patients were randomly assigned in 1:1 ratio to either control group or RIPC - group by means of a computerized randomization table.
Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Investigators
Blinded investigator, not involved in either CA or randomization procedure, performed assignment intervention.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

RIPC group

The RIPC group underwent Remote Ischemic Preconditioning.

Group Type EXPERIMENTAL

Remote Ischemic Preconditioning

Intervention Type PROCEDURE

four cycles of 5-min inflation to 200 mmHg followed by 5-min deflation of left upper - arm cuff

Control group

Patients from control group had sham Remote Ischemic Preconditioning.

Group Type SHAM_COMPARATOR

Sham Remote Ischemic Preconditioning

Intervention Type PROCEDURE

deflated cuff placed on the left arm for 40 min

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Remote Ischemic Preconditioning

four cycles of 5-min inflation to 200 mmHg followed by 5-min deflation of left upper - arm cuff

Intervention Type PROCEDURE

Sham Remote Ischemic Preconditioning

deflated cuff placed on the left arm for 40 min

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

RIPC Sham RIPC

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* aged over 18 years
* patients with stable angina pectoris
* patients admitted to Intensive Cardiac Therapy Clinic Medical University of Lodz with intention of elective CA with follow-up PCI.

Exclusion Criteria

* history of severe injuries up to 2 months before intervention
* history of surgeries up to 2 months before intervention
* history of cancer,
* acute inflammation during hospitalization
* chronic autoimmunologic diseases
* patients needing hemodialysis
* chronic kidney disease in stage 4 or 5 (eGFR\<30 ml/min/1,73m2)
* peripheral vascular disease affecting upper limbs.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of Lodz

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Karolina Stokfisz

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marzenna Zielinska, MD PhD

Role: STUDY_CHAIR

Medical University of Lodz

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Intensive Cardiac Therapy Clinic

Lodz, , Poland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Poland

References

Explore related publications, articles, or registry entries linked to this study.

Stokfisz K, Ledakowicz-Polak A, Kidawa M, Zielinska M. Remote Ischemic Preconditioning and Contrast-Induced Acute Kidney Injury in Patients Undergoing Elective Percutaneous Coronary Intervention: A Randomized Clinical Trial. Curr Ther Res Clin Exp. 2020 Aug 5;93:100599. doi: 10.1016/j.curtheres.2020.100599. eCollection 2020.

Reference Type DERIVED
PMID: 32874376 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Statistical Analysis Plan

View Document

Document Type: Study Protocol

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RNN/219/13/KE

Identifier Type: -

Identifier Source: org_study_id